Health Catalyst (HCAT) Stock
Healthcare data analytics platform for health systems. Here's the price, business snapshot, and what's worth knowing about Health Catalyst in August 2026.
Health Catalyst Inc (HCAT) is a healthcare data and analytics company that builds cloud-based platforms to help providers measure and improve clinical and financial outcomes. Its software combines data warehousing, analytics, and machine learning to support population health, care management and operational performance across hospitals and health systems. With a market capitalisation near $224m, HCAT is a relatively small, growth-oriented company that can be more volatile than larger peers. Revenue depends on adoption by health systems, recurring subscription contracts, and professional services. Investors should note competitive pressure from larger healthcare IT vendors, the pace of hospital digital transformation, and reimbursement or regulatory changes that affect customers’ budgets. This summary is educational, not personalised advice — values can rise and fall and returns are not guaranteed. Always check recent financials, management commentary and suitability for your objectives before considering any investment.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Health Catalyst's stock with a target price of $10.54, indicating growth potential.
Financial Health
Health Catalyst is performing well with strong revenue and cash flow, indicating good financial stability.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Data-driven healthcare
Platform analytics and machine learning can help hospitals improve outcomes and efficiency, though adoption cycles and competition can affect growth.
Health system focus
Customers are predominantly hospitals and health systems, so sector spending and regulation influence demand; performance can vary with policy changes.
Small-cap dynamics
With a modest market capitalisation, HCAT can offer growth potential but also greater share-price volatility and liquidity risk.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
